Octenidine Hydrochloride in Hydatid Disease

Hydatid disease remains a significant health issue in developing regions, where it causes substantial illness. Existing treatments have limitations in effectiveness and safety. Prior research has shown that saline solutions can kill hydatid cyst protoscoleces but may not be fully effective. This gap motivated the search for alternative agents with better scolicidal properties. No prior work had resolved whether octenidine hydrochloride could serve this purpose. The need for a more potent and safer option is clear. This study aimed to test octenidine's potential in this context. The findings could improve clinical protocols for managing hydatid disease.

The study aimed to evaluate octenidine hydrochloride's ability to kill hydatid cyst protoscoleces in vitro. It focused on comparing different concentrations and exposure times against a standard saline solution. The motivation was to find a more effective and practical scolicidal agent for clinical use. No prior work had tested octenidine in this role. The researchers wanted to determine if it could outperform saline. The study's design allowed for a direct comparison of efficacy. It also sought to identify optimal concentrations and exposure times. The results could guide future treatment strategies.

The study used hydatid cyst fluid obtained from patients and processed it to isolate protoscoleces. The cystic sand was exposed to octenidine at three concentrations: undiluted, 1%, and 0.1%. Each concentration was tested for 8 different exposure times ranging from 5 to 60 minutes. Saline at 20% concentration served as a control. Protoscoleces were observed for viability after exposure. The scolicidal effect was measured by counting dead protoscoleces. The experiment followed a controlled in vitro setup. Results were compared across concentrations and exposure times.

Undiluted octenidine achieved a strong scolicidal effect after 15 minutes, outperforming 20% saline. At 30 minutes, 1% octenidine showed comparable efficacy. However, 0.1% octenidine did not achieve significant scolicidal activity within 1 hour. The highest efficacy was observed with the highest concentration and shortest exposure time. These results suggest a dose-dependent effect of octenidine. The study's controlled design allowed for clear comparisons. No intermediate concentrations matched the undiluted solution's performance. The findings support the potential clinical use of undiluted or 1% octenidine.

The authors concluded that undiluted and 1% diluted octenidine may be suitable for scolicidal purposes in hydatid disease treatment. These concentrations achieved significant protoscolex death rates. The study's results suggest a practical alternative to saline solutions. No prior work had demonstrated octenidine's efficacy in this context. The findings support further clinical evaluation of the agent. The authors propose that these concentrations could improve treatment protocols. They emphasize the need for controlled trials to confirm these results. The study provides a foundation for future research on octenidine's role in hydatid disease.